Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594672943> ?p ?o ?g. }
- W2594672943 abstract "Low cardiac output syndrome remains a serious complication, and accounts for substantial morbidity and mortality in the postoperative course of paediatric patients undergoing surgery for congenital heart disease. Standard prophylactic and therapeutic strategies for low cardiac output syndrome are based mainly on catecholamines, which are effective drugs, but have considerable side effects. Levosimendan, a calcium sensitiser, enhances the myocardial function by generating more energy-efficient myocardial contractility than achieved via adrenergic stimulation with catecholamines. Thus potentially, levosimendan is a beneficial alternative to standard medication for the prevention of low cardiac output syndrome in paediatric patients after open heart surgery.To review the efficacy and safety of the postoperative prophylactic use of levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.We identified trials via systematic searches of CENTRAL, MEDLINE, Embase, and Web of Science, as well as clinical trial registries, in June 2016. Reference lists from primary studies and review articles were checked for additional references.We only included randomised controlled trials (RCT) in our analysis that compared prophylactic levosimendan with standard medication or placebo, in infants and children up to 18 years of age, who were undergoing surgery for congenital heart disease.Two review authors independently extracted data and assessed risk of bias according to a pre-defined protocol. We obtained additional information from all but one of the study authors of the included studies. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of evidence from the studies that contributed data to the meta-analyses for the prespecified outcomes. We created a 'Summary of findings' table to summarise the results and the quality of evidence for each outcome.We included five randomised controlled trials with a total of 212 participants in the analyses. All included participants were under five years of age. Using GRADE, we assessed there was low-quality evidence for all analysed outcomes. We assessed high risk of performance and detection bias for two studies due to their unblinded setting. Levosimendan showed no clear effect on risk of mortality (risk ratio (RR) 0.47, 95% confidence interval (CI) 0.12 to 1.82; participants = 123; studies = 3) and no clear effect on low cardiac output syndrome (RR 0.64, 95% CI 0.39 to 1.04; participants = 83; studies = 2) compared to standard treatments. Data on time-to-death were not available from any of the included studies.There was no conclusive evidence on the effect of levosimendan on the secondary outcomes. The length of intensive care unit stays (mean difference (MD) 0.33 days, 95% CI -1.16 to 1.82; participants = 188; studies = 4), length of hospital stays (MD 0.26 days, 95% CI -3.50 to 4.03; participants = 75; studies = 2), duration of mechanical ventilation (MD -0.04 days, 95% CI -0.08 to 0.00; participants = 208; studies = 5), and the risk of mechanical circulatory support or cardiac transplantation (RR 1.49, 95% CI 0.19 to 11.37; participants = 60; studies = 2) did not clearly differ between the groups. Published data about adverse effects of levosimendan were limited. A meta-analysis of hypotension, one of the most feared side effects of levosimendan, was not feasible because of the heterogeneous expression of blood pressure values.The current level of evidence is insufficient to judge whether prophylactic levosimendan prevents low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. So far, no significant differences have been detected between levosimendan and standard inotrope treatments in this setting.The authors evaluated the quality of evidence as low, using the GRADE approach. Reasons for downgrading were serious risk of bias (performance and detection bias due to unblinded setting of two RCTs), serious risk of inconsistency, and serious to very serious risk of imprecision (small number of included patients, low event rates)." @default.
- W2594672943 created "2017-03-16" @default.
- W2594672943 creator A5019261801 @default.
- W2594672943 creator A5023586883 @default.
- W2594672943 creator A5069956599 @default.
- W2594672943 date "2017-08-02" @default.
- W2594672943 modified "2023-09-26" @default.
- W2594672943 title "Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease" @default.
- W2594672943 cites W1477046628 @default.
- W2594672943 cites W1512904806 @default.
- W2594672943 cites W1972499281 @default.
- W2594672943 cites W1977467229 @default.
- W2594672943 cites W1993743949 @default.
- W2594672943 cites W1996945315 @default.
- W2594672943 cites W2001400624 @default.
- W2594672943 cites W2010048552 @default.
- W2594672943 cites W2015510321 @default.
- W2594672943 cites W2016475679 @default.
- W2594672943 cites W2022080260 @default.
- W2594672943 cites W2027898894 @default.
- W2594672943 cites W2031514364 @default.
- W2594672943 cites W2039418122 @default.
- W2594672943 cites W2046724909 @default.
- W2594672943 cites W2059969267 @default.
- W2594672943 cites W2061463574 @default.
- W2594672943 cites W2062487988 @default.
- W2594672943 cites W2067317899 @default.
- W2594672943 cites W2078671560 @default.
- W2594672943 cites W2080432415 @default.
- W2594672943 cites W2082370184 @default.
- W2594672943 cites W2085028768 @default.
- W2594672943 cites W2089335936 @default.
- W2594672943 cites W2089707647 @default.
- W2594672943 cites W2093015734 @default.
- W2594672943 cites W2095687684 @default.
- W2594672943 cites W2098055101 @default.
- W2594672943 cites W2105443169 @default.
- W2594672943 cites W2117483856 @default.
- W2594672943 cites W2127651839 @default.
- W2594672943 cites W2129122528 @default.
- W2594672943 cites W2135242378 @default.
- W2594672943 cites W2138373808 @default.
- W2594672943 cites W2138920742 @default.
- W2594672943 cites W2141900287 @default.
- W2594672943 cites W2143350455 @default.
- W2594672943 cites W2144615548 @default.
- W2594672943 cites W2156098321 @default.
- W2594672943 cites W2157204705 @default.
- W2594672943 cites W2160312646 @default.
- W2594672943 cites W2169629898 @default.
- W2594672943 cites W2252893192 @default.
- W2594672943 cites W2317813148 @default.
- W2594672943 cites W2325219355 @default.
- W2594672943 cites W2408525014 @default.
- W2594672943 cites W2442246762 @default.
- W2594672943 cites W2991792334 @default.
- W2594672943 cites W1511430208 @default.
- W2594672943 doi "https://doi.org/10.1002/14651858.cd011312.pub3" @default.
- W2594672943 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6483297" @default.
- W2594672943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28770972" @default.
- W2594672943 hasPublicationYear "2017" @default.
- W2594672943 type Work @default.
- W2594672943 sameAs 2594672943 @default.
- W2594672943 citedByCount "16" @default.
- W2594672943 countsByYear W25946729432017 @default.
- W2594672943 countsByYear W25946729432018 @default.
- W2594672943 countsByYear W25946729432020 @default.
- W2594672943 countsByYear W25946729432021 @default.
- W2594672943 countsByYear W25946729432022 @default.
- W2594672943 countsByYear W25946729432023 @default.
- W2594672943 crossrefType "journal-article" @default.
- W2594672943 hasAuthorship W2594672943A5019261801 @default.
- W2594672943 hasAuthorship W2594672943A5023586883 @default.
- W2594672943 hasAuthorship W2594672943A5069956599 @default.
- W2594672943 hasBestOaLocation W25946729432 @default.
- W2594672943 hasConcept C126322002 @default.
- W2594672943 hasConcept C141071460 @default.
- W2594672943 hasConcept C142724271 @default.
- W2594672943 hasConcept C164705383 @default.
- W2594672943 hasConcept C168563851 @default.
- W2594672943 hasConcept C177713679 @default.
- W2594672943 hasConcept C204787440 @default.
- W2594672943 hasConcept C27081682 @default.
- W2594672943 hasConcept C2777335384 @default.
- W2594672943 hasConcept C2778198053 @default.
- W2594672943 hasConcept C2778789114 @default.
- W2594672943 hasConcept C2779134260 @default.
- W2594672943 hasConcept C2780074459 @default.
- W2594672943 hasConcept C71924100 @default.
- W2594672943 hasConceptScore W2594672943C126322002 @default.
- W2594672943 hasConceptScore W2594672943C141071460 @default.
- W2594672943 hasConceptScore W2594672943C142724271 @default.
- W2594672943 hasConceptScore W2594672943C164705383 @default.
- W2594672943 hasConceptScore W2594672943C168563851 @default.
- W2594672943 hasConceptScore W2594672943C177713679 @default.
- W2594672943 hasConceptScore W2594672943C204787440 @default.
- W2594672943 hasConceptScore W2594672943C27081682 @default.
- W2594672943 hasConceptScore W2594672943C2777335384 @default.
- W2594672943 hasConceptScore W2594672943C2778198053 @default.
- W2594672943 hasConceptScore W2594672943C2778789114 @default.